PHOTOFRIN (porfimer sodium)
ANTINEOPLASTIC - PHOTOSENSITIZERS · NON-SMALL CELL LUNG CANCER ·+2
PINNACLE BIOLOG
Drug class
Antineoplastic - Photosensitizers
Antineoplastic photosensitizers are therapeutic agents used in photodynamic and photopheresis therapies that selectively accumulate in malignant or abnormal cells. Read more about Antineoplastic - Photosensitizers
2 drugs in this class 2 manufacturers
Drugs in Antineoplastic - Photosensitizers
UVADEX (methoxsalen)
ANTINEOPLASTIC - PHOTOSENSITIZERS · CUTANEOUS T-CELL LYMPHOMA
THERAKOS INC
Filter & compare in the drug finder →
Opens the drug finder with Antineoplastic - Photosensitizers preselected. Add indication or manufacturer filters there.
Antineoplastic photosensitizers are therapeutic agents used in photodynamic and photopheresis therapies that selectively accumulate in malignant or abnormal cells.
Upon activation by specific wavelengths of visible or near-infrared light, these compounds generate cytotoxic reactive oxygen species, such as singlet oxygen, leading to localized cellular apoptosis, necrosis, and targeted tumor tissue destruction.
Major indications include the palliation and ablation of non-small cell lung cancer, esophageal cancer, high-grade dysplasia in Barrett’s esophagus, superficial cutaneous malignancies, and cutaneous T-cell lymphoma.
-
cancer.gov
Antineoplastic photosensitizers are therapeutic agents used in photodynamic and photopheresis therapies that selectively accumulate in malignant or abnormal cells Upon activation by specific wavelengths of visible or near-infrared light, these compounds generate cytotoxic reactive oxygen species, such as singlet oxygen, leading to localized cellular apoptosis, necrosis, and targeted tumor tissue destruction
-
cancer.gov
Upon activation by specific wavelengths of visible or near-infrared light, these compounds generate cytotoxic reactive oxygen species, such as singlet oxygen, leading to localized cellular apoptosis, necrosis, and targeted tumor tissue destruction
-
pihhealth.org
Major indications include the palliation and ablation of non-small cell lung cancer, esophageal cancer, high-grade dysplasia in Barrett’s esophagus, superficial cutaneous malignancies, and cutaneous T-cell lymphoma
-
memorialcareselecthealthplan.org
Major indications include the palliation and ablation of non-small cell lung cancer, esophageal cancer, high-grade dysplasia in Barrett’s esophagus, superficial cutaneous malignancies, and cutaneous T-cell lymphoma
-
osu.edu
Major indications include the palliation and ablation of non-small cell lung cancer, esophageal cancer, high-grade dysplasia in Barrett’s esophagus, superficial cutaneous malignancies, and cutaneous T-cell lymphoma
-
cancer.gov
Major indications include the palliation and ablation of non-small cell lung cancer, esophageal cancer, high-grade dysplasia in Barrett’s esophagus, superficial cutaneous malignancies, and cutaneous T-cell lymphoma
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.